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Tumour-associated carbohydrate antigen (TACA) Tn is
always observed on the cell surface of malignant tumour
cells. Tn is presented as mucin-type carbohydrate. It has
been reported to be associated with cancer progression,
but the regulation on Tn expression in cancer cells is
not fully understood. In this study, we took an effort to
explore the mechanism of how Tn expression is regu-
lated in cancer cells. We observed that Tn expression in
cancer cells was decreased by changing to fresh medium
every 24 h. If we keep cancer cells in continuous cul-
tured medium, we observed that Tn expression was ele-
vated. We further showed that adding continuous
cultured medium to cancer cells which change to fresh
medium every 24 hours resulted in an induction of Tn
expression. These observations suggest that cancer cells
may autocrine some substance to stimulate Tn expres-
sion. We have identified at least two cytokines, TNF-a
and IL-6, that are autocrined by cancer cells and both
cytokines can induce Tn expression. We further demon-
strated that the induction of Tn expression can be dri-
ven by ras oncogene. This study thus indicates that
tumor microenviroment contributed by cancer cell
oncogene and by autocrine of cytokines is an important
factor in regulation of Tn expression.
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